Literature DB >> 9407226

Ex vivo phosphorus magnetic resonance spectroscopy on eye bank corneas and corneal metabolic health.

J V Greiner1, T Glonek, J H Lass, K Tsubota, K R Kenyon, J Shimazaki, P Meneses, K Hirokawa, T E Merchant, S L Hearn.   

Abstract

BACKGROUND: Since a potential exists for untoward effects on the cornea from the high magnetic fields and radio-frequency energies, and the further manipulation required for phosphorus-31 magnetic resonance spectroscopy (31P-MRS), we determined the effects of this technology on tissues using paired human corneas (n = 4) meeting criteria acceptable for transplantation.
METHODS: Slit-lamp biomicroscopy, pachometry, specular microscopy, and redux fluorophotometry were performed on all corneas. One cornea of each pair was examined (< 30 min) by 31P-MRS. Following 31P-MRS, slit-lamp biomicroscopy, pachometry, and redox fluorophotometry were again performed.
RESULTS: Data tabulated included the 31P energy modulus (1.37 +/- 0.28), the ATP/Pi (2.92 +/- 0.59) and SP/Pi (0.76 +/- 0.04) ratios, and the intracorneal pH (7.24 +/- 0.09).
CONCLUSION: Since there were no significant differences in slit-lamp biomicroscopy, endothelial density and morphometry, cell counts, and pachometric and redox fluorophotometric measurements between corneas of each pair before and after 31P-MRS analysis, it was concluded that there was no detectable metabolic damage secondary to such analysis. This study suggests that MRS analysis of human eye-bank tissues does not damage the cornea metabolically and may provide a practical evaluation of the health of the cornea at the biochemical level.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407226     DOI: 10.1007/bf01880667

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  13 in total

1.  Effects of moist-chamber and McCarey-Kaufman medium storage on the metabolic status of the cornea: a 31P-magnetic resonance analysis.

Authors:  J H Lass; J V Greiner; S K Medcalf; M R Kralik; P Meneses; T Glonek
Journal:  Ophthalmic Res       Date:  1988       Impact factor: 2.892

2.  Preoperative metabolic analysis of donor corneas using magnetic resonance spectroscopy.

Authors:  J H Lass; S K Medcalf; J V Greiner; T Glonek
Journal:  Cornea       Date:  1987       Impact factor: 2.651

3.  Longitudinal (T1) relaxation times of phosphorus metabolites in the bovine and rabbit lens.

Authors:  T Schleich; J A Willis; G B Matson
Journal:  Exp Eye Res       Date:  1984-10       Impact factor: 3.467

4.  Noninvasive metabolic analysis of eye bank corneas: a magnetic resonance spectroscopic study.

Authors:  J V Greiner; J H Lass; T Glonek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

5.  Ex vivo metabolic analysis of eye bank corneas using phosphorus nuclear magnetic resonance.

Authors:  J V Greiner; J H Lass; T Glonek
Journal:  Arch Ophthalmol       Date:  1984-08

6.  Glycolytic activity in the human cornea monitored with nuclear magnetic resonance spectroscopy.

Authors:  J D Gottsch; C H Chen; J B Aguayo; J P Cousins; E R Strahlman; W J Stark
Journal:  Arch Ophthalmol       Date:  1986-06

7.  Phosphorus nuclear magnetic resonance and ocular metabolism.

Authors:  J V Greiner; S J Kopp; T Glonek
Journal:  Surv Ophthalmol       Date:  1985 Nov-Dec       Impact factor: 6.048

8.  Phosphatic metabolites of the intact cornea by phosphorus-31 nuclear magnetic resonance.

Authors:  J V Greiner; S J Kopp; T E Gillette; T Glonek
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-05       Impact factor: 4.799

9.  Organophosphates of the crystalline lens: a nuclear magnetic resonance spectroscopic study.

Authors:  J V Greiner; S J Kopp; D R Sanders; T Glonek
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-11       Impact factor: 4.799

10.  Metabolic status of fresh v eye-bank-processed corneas. A phosphorus nuclear magnetic resonance study.

Authors:  J V Greiner; J H Lass; T Glonek
Journal:  Arch Ophthalmol       Date:  1984-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.